Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genetic Technologies ( (AU:GTG) ) has shared an announcement.
Genetic Technologies Limited has announced that director William Anthony Musgrave ceased to be a director of the company on 24 March 2026. According to the final director’s interest notice lodged with the ASX, Musgrave held no relevant interests in the company’s securities or related contracts at the time of his departure.
The filing underscores that there are no disclosed shareholdings or indirect interests associated with Musgrave following his exit from the board. This clean separation suggests limited immediate impact on the company’s ownership structure, though it marks a governance change that investors may monitor for any subsequent board or strategic adjustments.
The most recent analyst rating on (AU:GTG) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Genetic Technologies stock, see the AU:GTG Stock Forecast page.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology sector, focusing on genetic analysis and related life sciences services. The company is listed on the ASX and is subject to Australian corporate and securities regulation, including director disclosure requirements under the Corporations Act and ASX listing rules.
Technical Sentiment Signal: Sell
Current Market Cap: A$5.67M
See more insights into GTG stock on TipRanks’ Stock Analysis page.